Dual-Electrode Analyte Sensor Signal Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for monitoring blood glucose levels in diabetic patients are invasive, inconvenient, and often fail to detect hyperglycemic or hypoglycemic conditions in a timely manner, leading to dangerous side effects due to the lack of continuous and accurate glucose monitoring.
Innovation Solution
A dual-electrode continuous analyte sensor system is applied to a host, featuring a first working electrode beneath an enzymatic membrane portion and a second working electrode beneath a non-enzymatic membrane portion, which processes signals to isolate the analyte signal from non-analyte related electroactive compounds using a scaling factor, allowing for continuous and accurate glucose monitoring.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a single point blood glucose meter is used for conventional testing, then the measurement is simple and quick, but the monitoring is discontinuous and misses hyperglycemic or hypoglycemic conditions
Solution Approach 1:
The patent implements continuous glucose monitoring by maintaining constant contact between the sensor electrode and interstitial fluid through a transdermal interface, enabling uninterrupted measurement of glucose levels over extended periods rather than discrete point measurements
2Reliability
If finger pricking or blood draws are performed frequently for glucose monitoring, then more data points are obtained, but patient comfort deteriorates and hospital staff burden increases
Solution Approach 1:
The patent replaces the mechanical intrusion of finger pricking and blood draws with a non-invasive transdermal electrochemical sensor that measures glucose in interstitial fluid through the skin, eliminating pain and discomfort while maintaining continuous monitoring capability
Solution Approach 2:
The patent uses interstitial fluid as an intermediary medium to indirectly measure blood glucose levels, avoiding direct blood sampling while obtaining correlated glucose data through a less invasive transdermal interface
3Device complexity
If conventional single-electrode sensors are used, then the device structure is simple, but the sensor cannot distinguish analyte signal from non-analyte related electroactive compounds
Solution Approach 1:
The patent divides the sensing function into two separate electrodes: a first electrode with an enzyme layer specific to glucose that detects both analyte and non-analyte electroactive compounds, and a second electrode without the enzyme layer that detects only non-analyte electroactive compounds, enabling differential measurement and improved accuracy
Solution Approach 2:
The patent applies the enzyme layer selectively only to the first electrode while leaving the second electrode without this layer, creating local functional differences that enable the first electrode to detect glucose specifically while the second electrode measures interference from non-analyte compounds
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides continuous, accurate monitoring of blood glucose levels, reducing the risk of undetected hyperglycemic or hypoglycemic events and enabling more informed insulin therapy decisions.
Implementation Method 1
the enzymatic portion comprises an enzyme for detecting an analyte
Implementation Method 2
an analyte (or a species derived from it) that is electro-active generates a detectable signal at an electrode
Implementation Method 3
an electrochemical cell to provide output signals by which the presence or absence of an analyte, such as glucose, in a sample can be determined
Implementation Method 4
receiving a first signal from the first working electrode associated with the analyte and non-analyte related electroactive compounds, and receiving a second signal from the second working electrode associated with the non-analyte related electroactive compounds
Data Source
AI summary
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.